SIGHT DIAGNOSTICS LTD recalls Sight OLO, Automated Hematology Analyzer, Catalog No. OLO-U1
- Recall date
- June 14, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1469-2022
- FDA classification
- Class II
- Brand / firm
- SIGHT DIAGNOSTICS LTD
- Sold / distributed
- Worldwide distribution - US Nationwide distribution in the states of Alabama, Arizona, California, Florida, Idaho, Illinois, Kansas, Kentucky, Massachusetts, Michigan, Minnesota, Mississippi, New Jersey, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin and the c…
Why it was recalled
The default reference ranges for MCH, MCHC, and RDW for age group "Child 2-11y" are mixed up and incorrectly displayed on OLO devices running software version 2.63, 2.63.1, and 2.63.1.1. Due to the issue, results may incorrectly appear to be within or outside the reference range.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sight OLO, Automated Hematology Analyzer, Catalog No. OLO-U1
Get recall alerts
Free email alert whenever SIGHT DIAGNOSTICS LTD has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SIGHT DIAGNOSTICS LTD